New hope for pancreatic cancer: pill aims to boost radiation power
NCT ID NCT06141031
Summary
This early-stage trial is testing if adding an experimental pill called TTI-101 to a targeted form of radiation (SBRT) is safe and can help control pancreatic cancer for longer. It's for adults with borderline or locally advanced pancreatic cancer who have already completed standard chemotherapy. The main goal is to find the right dose and see if this combination can delay the cancer's return.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado
Aurora, Colorado, 80045, United States
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Conditions
Explore the condition pages connected to this study.